market intelligence

Ferma Agents

Identify breakthrough pharmaceutical signals and create competitive battlecards in minutes with AI agents that connect clinical data, SEC filings, and global intel.

Paid only

Price not published

Ferma Agents screenshot

About Ferma Agents

Ferma Agents is an advanced AI-powered market intelligence platform specifically engineered for the pharmaceutical and life sciences industries. Developed by ZoomRx, a firm trusted by the majority of the world's top pharma companies, this tool automates the intensive labor associated with competitive intelligence. It functions by deploying AI agents that monitor high-impact data sources around the clock, ensuring that strategic teams never miss a critical signal. Instead of manually scouring databases, users can rely on the platform to aggregate findings from ClinicalTrials.gov, SEC filings, PubMed, and even exclusive native-language intelligence from the Chinese pharmaceutical market. The platform operates by connecting disparate data points to form a cohesive strategic narrative. It does not just list clinical trials; it links those trials to specific drug assets, the firms developing them, their financial health, and their overall commercial strategy. For example, a user can track a competitor’s Phase 3 primary endpoint changes alongside their 8-K filings and CEO commentary from earnings calls. This synthesis allows for the creation of sophisticated competitive battlecards and partnership target assessments in a fraction of the time it would take a human analyst. The integrated chat interface further allows professionals to probe the data, asking complex questions about valuation risks or benchmarking efficacy against the standard of care. This tool is primarily designed for business development (BD) teams, competitive intelligence (CI) professionals, and clinical strategy leads within the biotech and pharmaceutical sectors. It is particularly effective for those working in fast-moving therapeutic areas like oncology or GLP-1/GIP weight loss treatments, where early signal detection can mean the difference between a successful acquisition and a missed opportunity. Investment analysts also benefit from the tool’s ability to calculate cash runways and identify companies under financial pressure that may be seeking strategic alternatives or partnerships. What sets Ferma Agents apart from legacy databases such as Cortellis or Evaluate Pharma is its transition from static data snapshots to living intelligence. While traditional platforms provide raw exports that require significant manual formatting, Ferma Agents can generate finished, stakeholder-ready slide decks directly in a user’s specific templates. This automation allows researchers to own the narrative while the AI handles the grunt work of data visualization. Furthermore, its specialized coverage of Chinese medical breakthroughs provides a competitive edge in a globalized market that is often underserved by Western-centric intelligence tools.

Ferma Agents pros & cons

Pros

  • Provides real-time living intelligence rather than static database snapshots.
  • Includes specialized native-language monitoring for the Chinese pharmaceutical market.
  • Automatically formats complex data into stakeholder-ready slide templates.
  • Connects clinical trial data directly to financial pressure and M&A signals.
  • Trusted by 19 of the top 20 global pharmaceutical firms.

Cons

  • Pricing is not transparently listed and requires booking a demo.
  • Maximum effectiveness requires users to encode their own specific playbooks.
  • Highly specialized for pharma, making it less applicable to other industries.

Ferma Agents use cases

  • Business Development teams can identify biotech targets with superior efficacy and short cash runways for acquisition.
  • Competitive Intelligence analysts can automate the tracking of competitor trial endpoint changes and investor day signals.
  • Clinical Researchers can benchmark emerging drug assets against current standards of care using cross-trial analysis.
  • Investment Analysts can monitor SEC filings and CEO commentary to predict potential strategic alternatives and M&A activity.

Ferma Agents features

  • automated battlecard creation
  • financial runway calculation
  • automated slide deck generation
  • native-language china intel
  • sec 8-k material signal tracking
  • cross-trial efficacy analysis
  • clinical trial benchmarking
  • 24/7 signal monitoring

Ferma Agents pricing

Is Ferma Agents free? No, Ferma Agents doesn't offer a free plan.

Enterprise

Price varies

  • 24/7 living intelligence monitoring
  • Native-language China market coverage
  • Automated deck generation in custom templates
  • ClinicalTrials.gov & PubMed integration
  • SEC filing & 8-K signal detection
  • Custom playbook encoding
  • SOC2 Type II compliance
  • Interactive AI chat for data probing

Ferma Agents FAQs

What primary data sources does Ferma Agents monitor?

The platform tracks a wide range of critical sources including ClinicalTrials.gov, EudraCT, SEC filings (8-Ks, 10-Qs, 10-Ks), PubMed, and exclusive native-language Chinese medical intelligence.

Can I use my own presentation templates for reporting?

Yes, Ferma Agents is designed to turn raw insights into stakeholder-ready slide decks specifically using your organization's custom templates to save time on formatting.

How does Ferma Agents differ from traditional pharmaceutical databases?

Unlike static snapshots from tools like Cortellis, Ferma Agents provides living intelligence with 24/7 monitoring and the ability to encode your specific custom playbooks.

Is the platform secure for enterprise use?

Ferma Agents is SOC2 Type II compliant, ensuring that your strategic playbooks and accessed data are handled with industry-standard security and privacy protocols.

Ratings & reviews

No reviews yet. Be the first to share how Ferma Agents worked for you.